The M & A Researcher is a daily information service dedicated to providing in-depth research, data compilation, news coverage, and fact-based analysis of corporate merger and acquisition transactions for the merger/risk arbitrage community. Visit: The M & A Researcher (http://www.maresearch.com/)
The M & A Researcher is a daily information service dedicated to providing in-depth research, data compilation, news coverage, and fact-based analysis of corporate merger and acquisition transactions for the merger/risk arbitrage community.
Visit: The M & A Researcher (http://www.maresearch.com/)
I am a 54 year old , new trader with a year of many losses under my belt! I have finally figured out MY biggest problem trading , it was believing a well writen lie as the promoters do so well and convincingly .I am retired and looking for a piece of land out west to buy, grow a garden , relax and enjoy whatever God has in store for my last years.
Michael G Riley is currently a managing member of Coastal Management Group LLC a Rhode Island registered Investment Advisor. Michael retired from 25 active years on Wall Street in 2002 and in 2005 formed Coastal Management Group with longtime associates Daniel Mintz and Gary Herman. CMG LLC formed the hedge fund Narragansett Fund LLC in June 2006, named after the town where Michael lives in Rhode Island. Michael and his partners have extensive experience in managing and trading derivatives using both well known and proprietary techniques. Mr. Riley has traded for his own account and managed divisions of PaineWebber, LETCO, and most recently managing director at TD Securities (TD Bank). Michael has been quoted in Barron’s, Wall Street Transcript, NY Post, and various other print media. Michael has appeared on NBC news,Yahoo TV, and CNBC. Michael has spoken at Option Industry conferences and participated in industry efforts to promote the use of options in reducing portfolio risk. Recently Mr Riley lost his bid for US Congress from Rhode Island. Coastal Management Group LLC is and investment advisor focused on asset management, derivative products and portfolio protection. Coastal has offices in East Hampton NY, Eastport NY and Narragansett Rhode Island.
John M. Putnamhas been covering the Medical Device and Technology industry on Wall Street for more than 30 years. He previously served as Senior Medical Device Analyst at Dawson James and Stanford Financial Group. He also held similar positions at Smith Barney, Wellington Management, L.F. Rothschild, Alex Brown & Sons, Adams, Harkness & Hill, and Gruntal. He was also a principle and co-founder of Belmont Harbor Capital, a boutique investment research and merchant bank in Chicago.
As an analyst for the past three decades, Mr. Putnam has been responsible for the technology, fundamental, regulatory and reimbursement research of the medical device industry. He has extensive knowledge of many segments of the medical device and technology industry including cardiovascular, orthopedics, diagnostics, and urology and the healthcare information industry. He was one of the first analysts on Wall Street to identify angioplasty and Women’s Health as major investment opportunities. He has a strong financial background and actually enjoys reading and analyzing financial statements and performing due diligence. He also spent several years in Washington D.C., focusing on regulatory and reimbursement issues impacting the medical device industry.
In addition to strong writing and personal communications skill, Mr. Putnam also developed a proprietary research methodology that evaluates the competitive position of companies participating in a particular industry segment by analyzing their intellectual property as embodied in a company’s patent portfolio. This methodology can be used to perform strategic planning and business development. It identifies each company’s relative competitive position within a technology and can identify those companies that are either active or have become inactive in research and development in that specific technology. From a business development perspective it can also identify a patent portfolio that may no longer be relevant to its holder but that may be an opportunity for another company.
Mr. Putnam holds an MBA from The George Washington University and a BA from Baldwin-Wallace College. He is a Chartered Financial Analyst and a member of the Boston Security Analysts Society.